← back to search

Jonathan P. Sleeman

Karlsruhe Institute of Technology · DE
🔎 Find collaborators in Oncology · Cell Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Cell Biology
Research interest
Research interests include Proteoglycans and glycosaminoglycans research, Glycosylation and Glycoproteins Research, Cancer Cells and Metastasis, and Cell Adhesion Molecules Research.
h-index
60
citations
16,443
works
270
NIH funding
primary concept
email

Recent publications

IER2-induced senescence drives melanoma invasion through osteopontin
Oncogene 2021cited by 36position: lastdoi
Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer
Cancers 2021cited by 19position: middledoi
Cancer microenvironment and genomics: evolution in process
Clinical & Experimental Metastasis 2021cited by 15position: middledoi
Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance
EBioMedicine 2020cited by 60position: middledoi
EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
British Journal of Cancer 2020cited by 44position: middledoi
Id1 and Id3 Are Regulated Through Matrix‐Assisted Autocrine BMP Signaling and Represent Therapeutic Targets in Melanoma
Advanced Therapeutics 2020cited by 1position: lastdoi
Tspan8 is expressed in breast cancer and regulates E‐cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles
The Journal of Pathology 2019cited by 52position: middledoi
Loss of ASAP1 in mice impairs adipogenic and osteogenic differentiation of mesenchymal progenitor cells through dysregulation of FAK/Src and AKT signaling
PLoS Genetics 2019cited by 48position: lastdoi
Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
Cell Reports 2016cited by 118position: middledoi
Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes
Oncotarget 2016cited by 21position: middledoi
‘Normalizing’ the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin
Cell Death and Disease 2016cited by 20position: middledoi
A Systematic Approach to Defining the microRNA Landscape in Metastasis
Cancer Research 2015cited by 57position: middledoi
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer
International Journal of Cancer 2014cited by 35position: lastdoi
Abstract 1443: A systematic approach to the metastatically relevant microRNA landscape
Cancer Research 2014cited by 2position: middledoi
The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer
Clinical Cancer Research 2013cited by 48position: middledoi
CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a
PLoS ONE 2013cited by 44position: middledoi
Autochthonous Mouse Melanoma and Mammary Tumors do not Express the Pluripotency Genes Oct4 and Nanog
PLoS ONE 2013cited by 9position: lastdoi
RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development
Oncogene 2012cited by 29position: lastdoi
Tumor‐initiating properties of breast cancer and melanoma cells <i>in vivo</i> are not invariably reflected by spheroid formation <i>in vitro</i>, but can be increased by long‐term culturing as adherent monolayers
International Journal of Cancer 2012cited by 21position: lastdoi
Abstract 143: CD24 induced miR-21 regulation is mainly mediated through Src, and both (CD24, Src) are post-transcriptionally downregulated by miR-34a
Cancer Research 2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wilko Thiele · University Hospital Heidelberg6 papers (2012–2021)Sonja Thaler · University Hospital Heidelberg6 papers (2012–2021)Heike Allgayer · University Hospital Heidelberg5 papers (2012–2015)Melanie Rothley · University Hospital Heidelberg5 papers (2014–2021)Jörg H. Leupold · Heidelberg University4 papers (2013–2015)Giridhar Mudduluru · Children's Mercy Hospital4 papers (2012–2015)Marcus Schmidt · Universitäts Frauenklinik4 papers (2012–2021)Cristina Cotarelo · Johannes Gutenberg University Mainz3 papers (2016–2021)Arno Schad · University Hospital and Clinics3 papers (2012–2016)Caroline Schreiber · University Hospital Heidelberg3 papers (2012–2019)Maike Scharp · University Medical Centre Mannheim2 papers (2014–2015)Mohammed Abba · Heidelberg University2 papers (2014–2015)Natascha Cremers · University Hospital Heidelberg2 papers (2019–2021)Nitin Patil · Heidelberg University2 papers (2014–2015)Boyan K. Garvalov · University Hospital Heidelberg2 papers (2020–2021)Olga Oleksiuk · Heidelberg University2 papers (2014–2015)Jochen Utikal · German Cancer Research Center2 papers (2020–2021)Jasmin Batliner · University of Bern2 papers (2014–2015)Viktor Umansky · University Medical Center2 papers (2012–2013)Axel Benner · Cancer Research And Biostatistics2 papers (2014–2015)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Cell Biology →